Pages that link to "Q34935319"
Jump to navigation
Jump to search
The following pages link to LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis (Q34935319):
Displaying 50 items.
- 14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition (Q24313042) (← links)
- Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks (Q26752554) (← links)
- Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway (Q26797238) (← links)
- Targeting TGF-β signaling in cancer (Q27012443) (← links)
- Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy (Q27021750) (← links)
- TGF-β - an excellent servant but a bad master (Q27025590) (← links)
- SIBLINGs and SPARC families: their emerging roles in pancreatic cancer (Q27027759) (← links)
- Complexities of TGF-β targeted cancer therapy (Q27693607) (← links)
- TGFΒ-induced transcription in cancer (Q28075605) (← links)
- TGF-β signaling and its targeting for glioma treatment (Q28082042) (← links)
- Targeted destruction of the orchestration of the pancreatic stroma and tumor cells in pancreatic cancer cases: molecular basis for therapeutic implications (Q28269990) (← links)
- Anoikis resistance: an essential prerequisite for tumor metastasis (Q28397372) (← links)
- BMP-7 enhances cell migration and αvβ3 integrin expression via a c-Src-dependent pathway in human chondrosarcoma cells (Q28544902) (← links)
- TGFbeta Induces Binucleation/Polyploidization in Hepatocytes through a Src-Dependent Cytokinesis Failure (Q28554460) (← links)
- Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer (Q29547558) (← links)
- Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models (Q30412086) (← links)
- The involvement of insulin-like growth factor 2 binding protein 3 (IMP3) in pancreatic cancer cell migration, invasion, and adhesion (Q30641525) (← links)
- Targeting the transforming growth factor-beta signaling pathway in human cancer (Q33517772) (← links)
- SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells (Q33556577) (← links)
- The miR-424(322)/503 cluster orchestrates remodeling of the epithelium in the involuting mammary gland. (Q33588077) (← links)
- Two faces of TGF-beta1 in breast cancer (Q33661529) (← links)
- Noninvasive characterization of pancreatic tumor mouse models using magnetic resonance imaging (Q33679670) (← links)
- Antimetastatic role of Smad4 signaling in colorectal cancer (Q33698993) (← links)
- Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB (Q33799457) (← links)
- Pancreatic cancer: molecular pathogenesis and new therapeutic targets (Q33899954) (← links)
- Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer (Q33912255) (← links)
- RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells. (Q34048144) (← links)
- Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation (Q34163525) (← links)
- IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-β receptor on hepatic stellate cells in a JNK-dependent manner (Q34289189) (← links)
- Retracted: Concomitant Targeting of EGF Receptor, TGF-beta and Src Points to a Novel Therapeutic Approach in Pancreatic Cancer (Q34326442) (← links)
- MicroRNA-584 and the protein phosphatase and actin regulator 1 (PHACTR1), a new signaling route through which transforming growth factor-β Mediates the migration and actin dynamics of breast cancer cells (Q34332277) (← links)
- Oral poly(ADP-ribose) polymerase-1 inhibitor BSI-401 has antitumor activity and synergizes with oxaliplatin against pancreatic cancer, preventing acute neurotoxicity (Q34339861) (← links)
- Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1. (Q34487585) (← links)
- The microRNA 424/503 cluster reduces CDC25A expression during cell cycle arrest imposed by transforming growth factor β in mammary epithelial cells (Q34592870) (← links)
- Docetaxel-encapsulating small-sized polymeric micelles with higher permeability and its efficacy on the orthotopic transplantation model of pancreatic ductal adenocarcinoma (Q34835853) (← links)
- Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host. (Q34898405) (← links)
- TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation (Q34925405) (← links)
- Trimodal glioblastoma treatment consisting of concurrent radiotherapy, temozolomide, and the novel TGF-β receptor I kinase inhibitor LY2109761. (Q35042985) (← links)
- A mechanism linking Id2-TGFβ crosstalk to reversible adaptive plasticity in neuroblastoma (Q35078100) (← links)
- First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma (Q35111925) (← links)
- Modulation of pancreatic cancer chemoresistance by inhibition of TAK1 (Q35143975) (← links)
- A meta analysis of pancreatic microarray datasets yields new targets as cancer genes and biomarkers (Q35150412) (← links)
- Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway (Q35176346) (← links)
- Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype. (Q35227104) (← links)
- Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation (Q35228755) (← links)
- Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers (Q35490960) (← links)
- TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia (Q35690582) (← links)
- Pancreatic cancer stromal biology and therapy (Q35766799) (← links)
- FH535 inhibited metastasis and growth of pancreatic cancer cells (Q35846780) (← links)
- LY2109761 enhances cisplatin antitumor activity in ovarian cancer cells. (Q35854002) (← links)